Morning After The Morning's Trash In my last post , I focused on flaws in the medical device approval process. The Union of Concerned Scientists FDA at a Crossroads meeting also covered problems with drug approval. This is perhaps no better illustrated than by the disappointing decision by Secretary of Health Kathleen Sebelius to deny the emergency contraceptive, Plan B, over-the-counter status for women under the age of 17

See the article here:
Molecules to Medicine: Plan B: The Tradition of Politics at the FDA